185 related articles for article (PubMed ID: 30477913)
1. Systems Delivery Innovation for Alzheimer Disease.
Bott NT; Sheckter CC; Yang D; Peters S; Brady B; Plowman S; Borson S; Leff B; Kaplan RM; Platchek T; Milstein A
Am J Geriatr Psychiatry; 2019 Feb; 27(2):149-161. PubMed ID: 30477913
[TBL] [Abstract][Full Text] [Related]
2. Report on financing the new model of family medicine.
Spann SJ;
Ann Fam Med; 2004 Dec; 2 Suppl 3(Suppl 3):S1-21. PubMed ID: 15654084
[TBL] [Abstract][Full Text] [Related]
3. Waste in the US Health Care System: Estimated Costs and Potential for Savings.
Shrank WH; Rogstad TL; Parekh N
JAMA; 2019 Oct; 322(15):1501-1509. PubMed ID: 31589283
[TBL] [Abstract][Full Text] [Related]
4. 2021 Alzheimer's disease facts and figures.
Alzheimers Dement; 2021 Mar; 17(3):327-406. PubMed ID: 33756057
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of donepezil in moderate to severe Alzheimer disease.
Feldman H; Gauthier S; Hecker J; Vellas B; Hux M; Xu Y; Schwam EM; Shah S; Mastey V;
Neurology; 2004 Aug; 63(4):644-50. PubMed ID: 15326236
[TBL] [Abstract][Full Text] [Related]
6. Economic costs of diabetes in the US in 2002.
Hogan P; Dall T; Nikolov P;
Diabetes Care; 2003 Mar; 26(3):917-32. PubMed ID: 12610059
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the intensive outpatient clinic: study protocol for a prospective study of high-cost, high-need patients in the University of Utah Health system.
Bannon BL; Lucier M; Fagerlin A; Kim J; Kiraly B; Weir P; Ozanne EM
BMJ Open; 2019 Feb; 9(1):e024724. PubMed ID: 30782742
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
[TBL] [Abstract][Full Text] [Related]
9. Assessing the relationship between health utilities, quality of life, and health care costs in Alzheimer's disease: the CATIE-AD study.
Miller EA; Rosenheck RA; Schneider LS
Curr Alzheimer Res; 2010 Jun; 7(4):348-57. PubMed ID: 19715552
[TBL] [Abstract][Full Text] [Related]
10. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
[TBL] [Abstract][Full Text] [Related]
11. Estimating the potential cost savings from the New York University Caregiver Intervention in Minnesota.
Long KH; Moriarty JP; Mittelman MS; Foldes SS
Health Aff (Millwood); 2014 Apr; 33(4):596-604. PubMed ID: 24711320
[TBL] [Abstract][Full Text] [Related]
12. Alternative funding and delivery models: practice and prospects in Ontario.
Abelson J; Birch S
J Ambul Care Manage; 1993 Jul; 16(3):19-29. PubMed ID: 10126589
[No Abstract] [Full Text] [Related]
13. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
14. Costs associated with treatment of insomnia in Alzheimer's disease caregivers: a comparison of mindfulness meditation and cognitive behavioral therapy for insomnia.
Bentley TGK; Castillo D; Sadeghi N; Piber D; Carroll J; Olmstead R; Irwin MR
BMC Health Serv Res; 2022 Feb; 22(1):231. PubMed ID: 35183180
[TBL] [Abstract][Full Text] [Related]
15. 2023 Alzheimer's disease facts and figures.
Alzheimers Dement; 2023 Apr; 19(4):1598-1695. PubMed ID: 36918389
[TBL] [Abstract][Full Text] [Related]
16. Impact of rivastigmine on costs and on time spent in caregiving for families of patients with Alzheimer's disease.
Marin D; Amaya K; Casciano R; Puder KL; Casciano J; Chang S; Snyder EH; Cheng I; Cuccia AJ
Int Psychogeriatr; 2003 Dec; 15(4):385-98. PubMed ID: 15000418
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Cost-effectiveness of Drug Treatment for Alzheimer Disease in a Simulation Model That Includes Caregiver and Societal Factors.
Ito K; Chapman R; Pearson SD; Tafazzoli A; Yaffe K; Gurwitz JH
JAMA Netw Open; 2021 Oct; 4(10):e2129392. PubMed ID: 34677596
[TBL] [Abstract][Full Text] [Related]
18. The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy.
Cavallo MC; Fattore G
Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):184-90. PubMed ID: 9437435
[TBL] [Abstract][Full Text] [Related]
19. Substitution of outpatient hospital care with specialist care in the primary care setting: A systematic review on quality of care, health and costs.
van Hoof SJM; Quanjel TCC; Kroese MEAL; Spreeuwenberg MD; Ruwaard D
PLoS One; 2019; 14(8):e0219957. PubMed ID: 31369567
[TBL] [Abstract][Full Text] [Related]
20. The cost of Alzheimer's disease in managed care: a cross-sectional study.
Leon J; Neumann PJ
Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
